Solventum (SOLV)

• Market cap: $11.5B
• 1 day: 0.04%
• 5 days: -3.51%
• 1 month: -2.28%
• 3 months: -4.46%
• 6 months: 24.22%
• Year to date: -16.46%
• 1 year: -16.46%
• 5 years: -16.46%
• 10 years: -16.46%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.

Employees: 22,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

29% more capital invested

Capital invested by funds: $5.65B [Q2] → $7.31B (+$1.66B) [Q3]

25% more first-time investments, than exits

New positions opened: 145 | Existing positions closed: 116

22% more funds holding in top 10

Funds holding in top 10: 9 [Q2] → 11 (+2) [Q3]

3% more funds holding

Funds holding: 887 [Q2] → 916 (+29) [Q3]

1.37% less ownership

Funds ownership: 61.87% [Q2] → 60.5% (-1.37%) [Q3]

26% less call options, than puts

Call options by funds: $48M | Put options by funds: $64.8M

59% less repeat investments, than reductions

Existing positions increased: 173 | Existing positions reduced: 427

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $70 5% upside
• Avg. target: $75 12% upside
• High target: $82 23% upside

4 analyst ratings

• positive: 1 25%
• neutral: 3 75%
• negative: 0 0%

Mizuho Steven Valiquette 20% 1-year accuracy 1 / 5 met price target	5% upside $70	Neutral Initiated	4 Dec 2024
Morgan Stanley Patrick Wood 55% 1-year accuracy 6 / 11 met price target	9% upside $73	Equal-Weight Maintained	11 Nov 2024
Piper Sandler Jason Bednar 50% 1-year accuracy 19 / 38 met price target	12% upside $75	Neutral Maintained	8 Nov 2024
Stifel Rick Wise 62% 1-year accuracy 18 / 29 met price target	23% upside $82	Buy Initiated	8 Oct 2024